Comparably Awards

Best Company Culture 2021 (Small & Midsize Companies)

BlueRock Therapeutics, a wholly-owned and independently operated subsidiary of Bayer AG, is a leading engineered cell... read more

This company is accepting feedback from verified employees EMPLOYEE PARTICIPANTS: 73

TOTAL RATINGS: 2110

SETH ETTENBERG, PH.D. BlueRock Therapeutics' CEO

CEO: SETH ETTENBERG, PH.D.

...

SETH ETTENBERG, PH.D. BlueRock Therapeutics CEO Rating

BlueRock Therapeutics' CEO, SETH ETTENBERG, PH.D., has 73 employee ratings and a score of 89/100, placing them in the Top 5% of similar size companies on Comparably with 201-500 Employees and Top 5% of other companies in Boston. When breaking the CEO score down by factors such as department, gender, and ethnicity, we see that females at BlueRock Therapeutics rate SETH ETTENBERG, PH.D. higher than males, giving the CEO a score of 90/100.

Last updated 11 days ago.

Where This Score Ranks BlueRock Therapeutics' CEO Rating

TOP
5%
In the Top 5% of 2004 Similar Sized Companies on Comparably
TOP
5%
In the Top 5% of 266 Nearby Companies in Boston
1st
1st place versus 4 competitors rated on Comparably

Jan

Feb

Mar

Apr

May

A+89 / 100

Jul

BlueRock Therapeutics CEO SETH ETTENBERG, PH.D. Bio

Seth Ettenberg, PhD, is the current President and CEO of BlueRock Therapeutics. Seth served as Chief Scientific Officer at BlueRock from 2020 - 2021. Prior to joining BlueRock, Seth was a founding member of the Unum Therapeutics team, where he served as Chief Scientific Officer. Previously, Seth headed the Cambridge Site of Novartis’ Oncology Biotherapeutics, leading strategy, innovation, and implementation of drug development projects of Novartis Institutes for Biomedical Research (NIBR). In addition, Seth was responsible for building and leading the Novartis Cell and Gene Therapy research team in collaboration with the University of Pennsylvania to develop chimeric antigen receptor T-cell therapeutics. Seth received his formal scientific training at the Genetics Branch of the National Cancer Institute.

Who Ranks BlueRock Therapeutics' CEO Rating the Highest?

Department - HR 98/100

Department - Admin 94/100

Ethnicity - Hispanic or Latino 93/100

Who Ranks BlueRock Therapeutics' CEO Rating the Lowest?

Ethnicity - Other 75/100

Department - R&D 83/100

Department - Product 86/100

BlueRock Therapeutics CEO SETH ETTENBERG, PH.D. At a Glance

The CEO score provides an understanding of how employees feel about the CEO’s leadership style and effectiveness at BlueRock Therapeutics.

Based on 73 ratings, SETH ETTENBERG, PH.D. ranks right above Bristol Myers Squibb's CEO, Giovanni Caforio.

BlueRock Therapeutics' CEO is highly regarded by the HR department, the Admin department, and Hispanic or Latino employees. However, the R&D department and the Product department have a less favorable view of the CEO and believe there is room for improvement. Overall, the CEO score has remained stable over the last 90 days.